Cresset & Redx Pharma Form Drug Discovery Collaboration

Two UK firms have agreed to collaborate on drug discovery.

Two UK firms, Cresset Group and Redx Pharma, have signed a drug discovery collaboration which will give Redx Pharma access to Cresset’s publicly available and proprietary computational chemistry technologies for use on their portfolio of drug discovery programs.

In addition Cresset will provide consulting services in the area of candidate selection across a broad range of therapeutic areas and targets.

Rob Scoffin, CEO of Cresset said, “Cresset has developed an extensive range of consulting services around the critical areas of library design, compound design, virtual screening and lead optimization. In this case we will initially be focussing our skills on helping Redx with their lead candidate selection process, whilst the collaboration a